BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12762144)

  • 1. The 8th International Conference on Alzheimer's Disease and Related Disorders, July 20-25, 2002, Stockholm, Sweden.
    Kimberly WT; Kovacs DM; Walsh D; Lashuel H; Lemere CA
    Amyloid; 2003 Mar; 10(1):51-61. PubMed ID: 12762144
    [No Abstract]   [Full Text] [Related]  

  • 2. Proteolytic processing and degradation of Alzheimer's disease relevant proteins.
    Steiner H; Capell A; Haass C
    Biochem Soc Trans; 1999 Feb; 27(2):234-42. PubMed ID: 10093740
    [No Abstract]   [Full Text] [Related]  

  • 3. Protein degradation in Alzheimer's disease and aging of the brain.
    Tsuji T; Shimohama S
    Prog Mol Subcell Biol; 2002; 29():43-60. PubMed ID: 11908072
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of the proteasome in Alzheimer's disease.
    Checler F; da Costa CA; Ancolio K; Chevallier N; Lopez-Perez E; Marambaud P
    Biochim Biophys Acta; 2000 Jul; 1502(1):133-8. PubMed ID: 10899438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of the proteasome to the alpha-secretase pathway in Alzheimer's disease.
    Marambaud P; Rieunier F; Wilk S; Martinez J; Checler F
    Adv Exp Med Biol; 1997; 421():267-72. PubMed ID: 9330707
    [No Abstract]   [Full Text] [Related]  

  • 6. Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms.
    Forloni G; Terreni L; Bertani I; Fogliarino S; Invernizzi R; Assini A; Ribizzi G; Negro A; Calabrese E; Volonté MA; Mariani C; Franceschi M; Tabaton M; Bertoli A
    Neurobiol Aging; 2002; 23(5):957-76. PubMed ID: 12392798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presenilin modulates Pen-2 levels posttranslationally by protecting it from proteasomal degradation.
    Crystal AS; Morais VA; Fortna RR; Carlin D; Pierson TC; Wilson CA; Lee VM; Doms RW
    Biochemistry; 2004 Mar; 43(12):3555-63. PubMed ID: 15035625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease: finding the missing link.
    Senior K
    Mol Med Today; 1999 May; 5(5):188-9. PubMed ID: 10322307
    [No Abstract]   [Full Text] [Related]  

  • 9. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
    Selkoe DJ
    J Clin Invest; 2002 Nov; 110(10):1375-81. PubMed ID: 12438432
    [No Abstract]   [Full Text] [Related]  

  • 10. [Strategies for identification of secretases implicated in Alzheimer's disease].
    Marambaud P; Chevallier N; Lopez-Perez E; Drouot C; Vizzanova J; Fulcrand P; Martinez J; Wilk S; Checler F
    Ann Biol Clin (Paris); 1998; 56(3):277-84. PubMed ID: 9754260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer's disease.
    Huse JT; Doms RW
    Mol Neurobiol; 2000; 22(1-3):81-98. PubMed ID: 11414282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cell biological perspective on Alzheimer's disease.
    Annaert W; De Strooper B
    Annu Rev Cell Dev Biol; 2002; 18():25-51. PubMed ID: 12142279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases.
    Marin R; Fabelo N; Martín V; Garcia-Esparcia P; Ferrer I; Quinto-Alemany D; Díaz M
    Neurobiol Aging; 2017 Jan; 49():52-59. PubMed ID: 27768960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease-linked mutation of presenilin 2 (N141I-PS2) drastically lowers APPalpha secretion: control by the proteasome.
    Marambaud P; Alves da Costa C; Ancolio K; Checler F
    Biochem Biophys Res Commun; 1998 Nov; 252(1):134-8. PubMed ID: 9813158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.
    Nunan J; Shearman MS; Checler F; Cappai R; Evin G; Beyreuther K; Masters CL; Small DH
    Eur J Biochem; 2001 Oct; 268(20):5329-36. PubMed ID: 11606195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid, presenilins, and Alzheimer's disease.
    Van Gassen G; Annaert W
    Neuroscientist; 2003 Apr; 9(2):117-26. PubMed ID: 12708616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Presenilin, Notch, and the genesis and treatment of Alzheimer's disease.
    Selkoe DJ
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11039-41. PubMed ID: 11572965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The secretases of Alzheimer's disease.
    Wolfe MS
    Curr Top Dev Biol; 2003; 54():233-61. PubMed ID: 12696752
    [No Abstract]   [Full Text] [Related]  

  • 19. Alzheimer disease gamma-secretase: a complex story of GxGD-type presenilin proteases.
    Haass C; Steiner H
    Trends Cell Biol; 2002 Dec; 12(12):556-62. PubMed ID: 12495843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroscience. An accomplice for gamma-secretase brought into focus.
    Sisodia SS
    Science; 2000 Sep; 289(5488):2296-7. PubMed ID: 11041797
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.